FDA approves Tremfya for active Crohn's disease in adults
The U.S. Food and Drug Administration has approved Johnson & Johnson's Tremfya (guselkumab) for adult patients with ...
Medscape12h
FDA OKs Guselkumab for Crohn’s Disease
Guselkumab is the first and only interleukin-23 inhibitor that offers both subcutaneous and intravenous induction options for ...
Rolling Out6d
Key signs that might indicate you have Crohn’s disease
Crohn's disease belongs to a group of conditions known as inflammatory bowel diseases (IBD). This chronic condition causes ...
Healio5h
Extended treatment with Skyrizi ‘may ultimately benefit’ refractory Crohn’s disease
Patients with moderate to severe Crohn’s disease who did not achieve clinical response to IV induction with Skyrizi ...
Diets filled with nutrient-dense plant foods tied to lower IBD risk
A plant-based diet made up of mainly nutrient-dense plant foods, or an equally healthy omnivorous diet may help reduce the ...
MPR1d
Tremfya Approved for Moderately to Severely Active Crohn Disease
The Food and Drug Administration (FDA) has approved Tremfya ® (guselkumab) for the treatment of adults with moderately to severely active Crohn disease (CD).
Healio4d
Tremfya’s FDA win as fully subcutaneous option for Crohn’s may pave way to eclipse Stelara
The FDA has approved Tremfya as the “first and only” interleukin-23 inhibitor that offers both IV and fully subcutaneous ...
Science Daily2d
Cellular mechanisms that may lead to onset of inflammatory bowel disease
New study shows that dysfunction of protective immune cells in GI tract may contribute to onset of inflammation in Crohn's disease.
Medscape6d
Can Ileocaecal Resection Cut Corticosteroid Use in Crohn's?
In patients with Crohn's disease and intermediate to high preoperative corticosteroid use, primary ileocaecal resection leads ...
FDA Approves Tremfya for Active Crohn Disease in Adults
Tremfya is the first and only interleukin-23 inhibitor offering both subcutaneous and intravenous induction options for Crohn ...
Health and Me on MSN15h
FDA Approves Tremfya For Active Crohn's Disease
Crohn's disease is a type of inflammatory bowel disease (IBD) that causes swelling and irritation of the tissues, called ...